Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 juil. 2021 12h51 HE | Source: Ischemix, Inc.

Ischemix, Inc. Receives US Department of Defense Funding of $2.9 million to Conduct Phase 1 Study of Drug Candidate to Treat Traumatic Brain Injury (TBI)

GRAFTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Ischemix, Inc., a private company focused on developing therapeutics for serious medical conditions, today announced that the US Department of...
25 mars 2019 18h39 HE | Source: Ischemix, Inc.

Novel compound for treatment of traumatic brain injury (TBI) demonstrates positive results in a preclinical study

Strongest announced preclinical results of any drug candidate currently in development for TBI Significant results in neurobehavior as measured by actigraphy. GRAFTON, Mass., March 25, 2019 (GLOBE...